INTU vs PCSA · P/E 64, rev $18.83B vs $5.9M cap
Intuit Inc (INTU) versus Processa Pharmaceuticals Inc (PCSA) — a side-by-side from cached financials, not a winner call.
Intuit Inc (INTU) is a software - application company listed on US.
Processa Pharmaceuticals Inc (PCSA) is a biotechnology company listed on NASDAQ.
Latest reported INTU revenue for 2025-07-31 was $18.83B. Net income was $3.87B. INTU currently screens at market cap $217.76B and trailing P/E 63.7.
PCSA does not have a complete income-statement cache yet.
INTU currently screens at market cap $217.76B and trailing P/E 63.7. PCSA currently screens at market cap $5.9M.
Not investment advice. Open the INTU and PCSA stock pages for the full models.
Not investment advice.